Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Assets: 2011-2024

Historic Return on Assets for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Dec 2024 value amounting to 0.25%.

  • Ironwood Pharmaceuticals' Return on Assets rose 94.00% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 94.00%. This contributed to the annual value of 0.25% for FY2024, which is 185.00% up from last year.
  • According to the latest figures from FY2024, Ironwood Pharmaceuticals' Return on Assets is 0.25%, which was up 115.62% from -1.60% recorded in FY2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Assets peaked at 0.63% during FY2021, and registered a low of -1.60% during FY2023.
  • For the 3-year period, Ironwood Pharmaceuticals' Return on Assets averaged around -0.40%, with its median value being 0.16% (2022).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Return on Assets slumped by 176bps in 2023, and later soared by 185bps in 2024.
  • Ironwood Pharmaceuticals' Return on Assets (Yearly) stood at 0.22% in 2020, then spiked by 41bps to 0.63% in 2021, then tumbled by 47bps to 0.16% in 2022, then plummeted by 176bps to -1.60% in 2023, then skyrocketed by 185bps to 0.25% in 2024.